Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mac Leckrone interview from April 07

The MMP Portfolio licensing program has, I think, proved its mettle. We expect a lot of licensees to come on board this year, because they see the issues. And then there’s a certain crowd that will just wait, and they’ll pay a lot more. We’re looking forward to that because at the end of the day, what we’re doing is funding an array of product development. That’s our cycle of success.

 

This is the best of the article. We could start to see larger and larger licineseing fees and settlements

Share
New Message
Please login to post a reply